Purpose: To report on images of the human photoreceptor mosaic acquired in vivo with a newly developed, compact adaptive optics (AO) fundus camera.
Methods: The photoreceptors of two normal subjects and a patient with macular dystrophy were examined by using an AO fundus camera equipped with a liquid crystal phase modulator. In the eye with macular dystrophy, the fixation point in the AO images was identified using scanning laser ophthalmoscope (SLO) microperimetric image superimposed on a color fundus photograph.
Results: Photoreceptor cells were detected as bright dots approximately 4 microm in diameter in normal subjects. In the eye with macular dystrophy, the fixation point was located within the bull's eye lesion and uniform small whitish spots with irregular patchiness were observed in the AO images of this area. The distance between the small spots was 3-4 microm. In other parts of the bull's eye retinal lesion, the whitish spots were larger and of different sizes.
Conclusions: The photoreceptor mosaic could be identified in photographs of eyes of normal subjects and an eye with macular dystrophy in vivo by an AO fundus camera. In the eye with macular dystrophy, a relatively uniform photoreceptor mosaic was observed around the fixation point, whereas presumed debris of photoreceptor degradation was observed in the other bull's eye retinal lesion.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s10384-008-0575-1 | DOI Listing |
Am J Ophthalmol Case Rep
December 2024
Genomic Laboratory, Umraniye Training and Research Hospital, University of Health Sciences, Istanbul, Turkey.
Purpose: To report the posterior segment findings in a case with a biallelic frameshift pathogenic variant at chromosome 10 c.616del exon7 p.(His206Thrfs∗61).
View Article and Find Full Text PDFCureus
November 2024
General Medicine, Barts Health National Health Service (NHS) Trust, London, GBR.
Anti-vascular endothelial growth factor (VEGF) drugs are used for various diseases with abnormal proliferation of blood vessels. The use of these drugs in wet age-related macular degeneration (AMD) has proven to be highly effective. Various factors contribute to the efficacy of these drugs in different settings.
View Article and Find Full Text PDFBMC Ophthalmol
December 2024
Genentech, Inc, South San Francisco, CA, USA.
Background: Intravitreal anti-vascular endothelial growth factor (VEGF) treatment for diabetic macular oedema (DME) may begin with several initial monthly doses. Characteristics, treatment patterns and outcomes were compared for eyes with DME that did and did not receive such initial doses.
Methods: This was a retrospective database study using American Academy of Ophthalmology Intelligent Research in Sight Registry data (01/01/15-31/12/20; index period).
Eur J Pharmacol
December 2024
Center of Clinical Research, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center, Nanjing Medical University, Wuxi, China. Electronic address:
Purpose: Age-related macular degeneration (AMD) is the leading cause of vision loss among the elderly individuals. Retinal pigment epithelium (RPE) ferroptosis is a significant pathogenetic component in AMD. This study aims to elucidate the role and mechanisms of fatty acid desaturase 1 (FADS1) in ferroptosis as well as AMD progression.
View Article and Find Full Text PDFBiochem Res Int
December 2024
Development of Research and Development, Sunshine Guojian Pharmaceutical (Shanghai) Co. Ltd., a 3SBio Inc. Company, 399 Libing Road, Shanghai 201203, China.
Age-related macular degeneration (AMD) is a severe eye disease in people aged 60 years and older. Although anti-VEGF therapies are effective in treating neovascular AMD (NvAMD) in the clinic, up to 60% of patients do not completely respond to the therapies. Recent studies have shown that blood-derived macrophages and their associated proinflammatory cytokines may play important roles in the development of persistent disease and resistance to anti-VEGF therapy.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!